|
Name |
7-Tetradecene
|
| Molecular Formula | C14H28 | |
| IUPAC Name* |
(E)-tetradec-7-ene
|
|
| SMILES |
CCCCCC/C=C/CCCCCC
|
|
| InChI |
InChI=1S/C14H28/c1-3-5-7-9-11-13-14-12-10-8-6-4-2/h13-14H,3-12H2,1-2H3/b14-13+
|
|
| InChIKey |
UBDIXSAEHLOROW-BUHFOSPRSA-N
|
|
| Synonyms |
7-TETRADECENE; trans-7-tetradecene; 10374-74-0; (E)-7-Tetradecene; 7-Tetradecene, (E)-; 41446-63-3; (7E)-7-Tetradecene; 7-Tetradecene, (7E)-; 3V3074NJ3L; (E)-tetradec-7-ene; UNII-3V3074NJ3L; e-7-tetradecene; E-Tetradec-7-ene; EINECS 233-815-7; trans-7-Tetradecene, 97%; 7-TETRADECENE, TRANS-; (7E)-TETRADEC-7-ENE; CHEBI:88616; DTXSID001020809; ZINC2539252; T0745; D92387; Q27160506
|
|
| CAS | 10374-74-0 | |
| PubChem CID | 5364651 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 196.37 | ALogp: | 6.9 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
| Heavy Atoms: | 14 | QED Weighted: | 0.311 |
| Caco-2 Permeability: | -4.619 | MDCK Permeability: | 0.00001460 |
| Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.48 |
| 30% Bioavailability (F30%): | 0.98 |
| Blood-Brain-Barrier Penetration (BBB): | 0.232 | Plasma Protein Binding (PPB): | 99.56% |
| Volume Distribution (VD): | 4.73 | Fu: | 1.49% |
| CYP1A2-inhibitor: | 0.792 | CYP1A2-substrate: | 0.22 |
| CYP2C19-inhibitor: | 0.535 | CYP2C19-substrate: | 0.112 |
| CYP2C9-inhibitor: | 0.29 | CYP2C9-substrate: | 0.954 |
| CYP2D6-inhibitor: | 0.474 | CYP2D6-substrate: | 0.25 |
| CYP3A4-inhibitor: | 0.328 | CYP3A4-substrate: | 0.068 |
| Clearance (CL): | 3.196 | Half-life (T1/2): | 0.354 |
| hERG Blockers: | 0.116 | Human Hepatotoxicity (H-HT): | 0.018 |
| Drug-inuced Liver Injury (DILI): | 0.046 | AMES Toxicity: | 0.003 |
| Rat Oral Acute Toxicity: | 0.022 | Maximum Recommended Daily Dose: | 0.078 |
| Skin Sensitization: | 0.941 | Carcinogencity: | 0.037 |
| Eye Corrosion: | 0.994 | Eye Irritation: | 0.944 |
| Respiratory Toxicity: | 0.219 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001677 | ![]() |
0.878 | D0O1TC | ![]() |
0.515 | ||
| ENC001690 | ![]() |
0.870 | D0O1PH | ![]() |
0.493 | ||
| ENC001693 | ![]() |
0.850 | D0UE9X | ![]() |
0.470 | ||
| ENC001681 | ![]() |
0.727 | D0OR6A | ![]() |
0.424 | ||
| ENC001655 | ![]() |
0.711 | D05ATI | ![]() |
0.359 | ||
| ENC001691 | ![]() |
0.704 | D09SRR | ![]() |
0.337 | ||
| ENC001706 | ![]() |
0.690 | D0Z5BC | ![]() |
0.333 | ||
| ENC001689 | ![]() |
0.656 | D0Z5SM | ![]() |
0.324 | ||
| ENC001645 | ![]() |
0.655 | D0H2YX | ![]() |
0.323 | ||
| ENC001694 | ![]() |
0.648 | D0XN8C | ![]() |
0.303 | ||